Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA crawled time : 08:00 save search
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
fda pharma program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 9.45%
H: 0.0%
C: -1.7%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -1.16%
H: 0.39%
C: -4.31%
sar4435 pharma iph6101 cell results sanofi
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published: 2023-11-07 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.31%
H: 2.76%
C: 1.18%
pharma conference business update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.85%
H: 12.13%
C: 3.77%
pharma
Innate Pharma Provides Update on Lacutamab Clinical Program
Published: 2023-10-05 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -9.31%
H: 7.14%
C: 7.14%
pharma update program
Innate Pharma Reports First Half 2023 Financial Results and Business Update
Published: 2023-09-14 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.14%
H: 0.0%
C: -1.3%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.74%
C: 0.33%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -5.23%
H: 6.9%
C: 5.74%
pharma business update financial results
Innate Pharma to Participate in Upcoming Investor Conference - August 10, 2023
Published: 2023-08-10 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 3.09%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.52%
H: 1.05%
C: 0.47%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.78%
H: 0.68%
C: 0.34%
pharma conference
Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update
Published: 2023-03-23 (Crawled : 08:00) - biospace.com/
BNPQF | $68.558 -13.4% 400
|
Finance
|
| O: 0.52%
H: 0.0%
C: -3.23%
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: 1.88%
H: 0.14%
C: -3.52%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 5.54%
H: 0.96%
C: 0.96%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 6.53%
H: 0.56%
C: -0.54%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: -11.3%
pharma business year update financial results
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
Published: 2022-12-01 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 5.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.64%
H: 2.88%
C: 2.88%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.25%
H: 0.2%
C: -0.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.96%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 4.56%
H: 1.86%
C: 1.86%
iph5201 pharma
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published: 2022-09-05 (Crawled : 08:00) - biospace.com/
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IPHYF | $2.65 104.6% 300
|
Health Technology
| Email alert
Add to watchlist
pharma platform phase 2b
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: -0.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.96%
H: 0.98%
C: -1.15%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
iph5201 pharma cancer phase 2
Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.96%
C: -0.04%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.4%
H: 1.38%
C: -0.35%
pharma conference
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -0.98%
H: 1.17%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.27%
H: 0.98%
C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.17%
results pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Feb 04, 2022
Published: 2022-02-04 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.02%
H: 0.52%
C: 0.0%
conference pharma
Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference
Published: 2021-11-24 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -2.48%
H: 1.68%
C: 0.42%
conference pharma
Number of Shares and Voting Rights of Innate Pharma as of October 1, 2021
Published: 2021-10-15 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.78%
H: 1.5%
C: 1.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.35%
H: 1.12%
C: 0.89%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.86%
H: 1.36%
C: -0.17%
pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Aug 30, 2021
Published: 2021-08-30 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.18%
H: 1.47%
C: 0.95%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: -0.28%
conference pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.